R
Raul D. Santos
Researcher at University of São Paulo
Publications - 463
Citations - 21660
Raul D. Santos is an academic researcher from University of São Paulo. The author has contributed to research in topics: Familial hypercholesterolemia & Medicine. The author has an hindex of 56, co-authored 404 publications receiving 16997 citations. Previous affiliations of Raul D. Santos include Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Abstract 12006: Lipoprotein(a), Coronary Atherosclerotic Plaque, and High-Risk Plaque in Asymptomatic Individuals: The Miami Heart Study at Baptist Health South Florida
Reed Mszar,Miguel Cainzos Achirica,Javier Valero Elizondo,Renato Quispe,Shozab S. Ali,Lara Arias,Anshul Saxena,Ricardo C. Cury,Matthew J. Budoff,Ted Feldman,Shubham Lahan,Michael J. Blaha,Michael D. Shapiro,Garima Sharma,Raul D. Santos,Jonathan Fialkow,Khurram Nasir +16 more
TL;DR: In this article , the authors examined the association between Lp(a) and coronary plaque characteristics in a diverse U.S. cohort free of clinical ASCVD and found that Lp ≥ 125 nmol/L was associated with higher prevalence of all outcomes compared with Lp <125 nmol /L, however, differences were only statistically significant for any coronary plaque and the presence of ≥ 2 high-risk features (positive remodeling, spotty calcification, lowattenuation plaque, napkin ring).
Journal ArticleDOI
Inclisiran, ARN interferente pequeño: un nuevo enfoque para el tratamiento del colesterol
María C. Fragozo-Ramos,Valeria Gómez-Sierra,Laura V. Gómez-Galvis,Rafael Campo,Raul D. Santos,Alejandro Román-González +5 more
TL;DR: Inclisiran as discussed by the authors is a small double-stranded small interfering RNA that acts by blocking PCSK-9 transcription in hepatocytes, leading to a marked and sustained reduction in circulating LDL-C levels.
Journal ArticleDOI
Assessing statins use in a real-world primary care digital strategy: a cross-sectional analysis of a population-wide digital health approach
M. Julia Machline-Carrion,Alysson Nathan Girotto,Josue Nieri,Frederico Monfardini,Francisco José Forestiero,Priscila Silva Raupp,Fabiana Roveda,Karla Santo,Otavio Berwanger,Raul D. Santos +9 more
TL;DR: In this paper , the authors conducted a cross-sectional study (ClinicalTrials.gov, NCT05285085) to assess the use of statins in secondary prevention populations.
editorialDOI
Coronary Artery and Thoracic Aorta Calcification and Cardiovascular Events in Severe Hypercholesterolemia: More Wood for the Cardiovascular Disease Risk Heterogeneity Bonfire!
Journal ArticleDOI
Pharmacological treatment with lipid-lowering agents after molecular identification of familial hypercholesterolemia: results from the Hipercol Brasil cohort.
Pamela R.S. Silva,Cinthia E. Jannes,Theo G M Oliveira,José Eduardo Krieger,Raul D. Santos,Alexandre C. Pereira +5 more
TL;DR: In this article , the authors studied the main predictors of the use of lipid-lowering agents at one-year follow-up in a large cohort of familial hypercholesterolemia patients.